Literature DB >> 27554298

Echocardiography Combined With Cardiopulmonary Exercise Testing for the Prediction of Outcome in Idiopathic Pulmonary Arterial Hypertension.

Roberto Badagliacca1, Silvia Papa2, Gabriele Valli2, Beatrice Pezzuto2, Roberto Poscia2, Giovanna Manzi2, Elisa Giannetta3, Susanna Sciomer2, Paolo Palange4, Robert Naeije5, Francesco Fedele2, Carmine Dario Vizza2.   

Abstract

BACKGROUND: Right ventricular (RV) function is a major determinant of exercise intolerance and outcome in idiopathic pulmonary arterial hypertension. The aim of the study was to evaluate the incremental prognostic value of echocardiography of the right ventricle and cardiopulmonary exercise testing (CPET) on long-term prognosis in these patients.
METHODS: One hundred and thirty treatment-naïve patients with idiopathic pulmonary arterial hypertension were enrolled and prospectively followed. Clinical worsening (CW) was defined by a reduction in 6-min walk distance plus an increase in functional class, or nonelective hospitalization for PAH, or death. Baseline evaluation included clinical, hemodynamic, echocardiographic, and CPET variables. Cox regression modeling with c-statistic and bootstrapping validation methods were done.
RESULTS: During a mean period of 528 ± 304 days, 54 patients experienced CW (53%). Among demographic, clinical, and hemodynamic variables at catheterization, functional class and cardiac index were independent predictors of CW (model 1). With addition of echocardiographic and CPET variables (model 2), peak O2 pulse (peak V˙o2/heart rate) and RV fractional area change (RVFAC) independently improved the power of the prognostic model (area under the curve, 0.81 vs 0.66, respectively; P = .005). Patients with low RVFAC and low O2 pulse (low RVFAC + low O2 pulse) and high RVFAC + low O2 pulse showed a 99.8 and 29.4 increase in the hazard ratio, respectively (relative risk, 41.1 and 25.3, respectively), compared with high RVFAC + high O2 pulse (P = .0001).
CONCLUSIONS: Echocardiography combined with CPET provides relevant clinical and prognostic information. A combination of low RVFAC and low O2 pulse identifies patients at a particularly high risk of clinical deterioration. Copyright Â
© 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiopulmonary exercise test; clinical worsening; echocardiography; pulmonary arterial hypertension; right ventricular systolic function

Mesh:

Year:  2016        PMID: 27554298     DOI: 10.1016/j.chest.2016.07.036

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertension.

Authors:  Hirohisa Amano; Shichiro Abe; Suguru Hirose; Ryutaro Waku; Taiki Masuyama; Masashi Sakuma; Shigeru Toyoda; Isao Taguchi; Teruo Inoue; Chuwa Tei
Journal:  Heart Vessels       Date:  2017-05-19       Impact factor: 2.037

2.  Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension.

Authors:  Anqi Duan; Xin Li; Qi Jin; Yi Zhang; Zhihui Zhao; Qing Zhao; Lu Yan; Zhihua Huang; Meixi Hu; Jiaran Liu; Chenhong An; Xiuping Ma; Changming Xiong; Qin Luo; Zhihong Liu
Journal:  Ther Adv Chronic Dis       Date:  2022-06-21       Impact factor: 4.970

Review 3.  The physiological basis of pulmonary arterial hypertension.

Authors:  Robert Naeije; Manuel J Richter; Lewis J Rubin
Journal:  Eur Respir J       Date:  2022-06-16       Impact factor: 33.795

4.  Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Yoshihiro Kamimura; Naoki Okumura; Shiro Adachi; Shigetake Shimokata; Fumitaka Tajima; Yoshihisa Nakano; Akihiro Hirashiki; Toyoaki Murohara; Takahisa Kondo
Journal:  Heart Vessels       Date:  2018-04-27       Impact factor: 2.037

5.  Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.

Authors:  Michele Correale; Ilenia Monaco; Armando Ferraretti; Lucia Tricarico; Monica Sicuranza; Anna Maria Gallotta; Ennio Sascia Formica; Gianfranco Acanfora; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-21

6.  Utilizing Machine Learning Techniques to Predict the Efficacy of Aerobic Exercise Intervention on Young Hypertensive Patients Based on Cardiopulmonary Exercise Testing.

Authors:  Fangwan Huang; Xiuyu Leng; Mohan Vamsi Kasukurthi; Yulong Huang; Dongqi Li; Shaobo Tan; Guiying Lu; Juhong Lu; Ryan G Benton; Glen M Borchert; Jingshan Huang
Journal:  J Healthc Eng       Date:  2021-04-21       Impact factor: 2.682

Review 7.  The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece.

Authors:  Cristiano Miotti; Silvia Papa; Giovanna Manzi; Gianmarco Scoccia; Federico Luongo; Federica Toto; Claudia Malerba; Nadia Cedrone; Susanna Sciomer; Francesco Ciciarello; Francesco Fedele; Carmine Dario Vizza; Roberto Badagliacca
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

8.  Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension.

Authors:  B Pezzuto; R Badagliacca; M Muratori; S Farina; M Bussotti; M Correale; A Bonomi; C Vignati; S Sciomer; S Papa; E Palazzo Adriano; P Agostoni
Journal:  Pulm Circ       Date:  2022-03-24       Impact factor: 2.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.